Guardian Pharmacy Services, Inc. reported $1.46B of revenue over the trailing twelve months, +10% on the year before. 7 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.46B (to Q2 2026). Net income: $66M, trailing twelve months to Q2 2026. Operating margin: 5.8%, trailing twelve months to Q2 2026.

GRDNGuardian Pharmacy Services, Inc.

Healthcare

$41.24+62% 1Y

$41.24

$23.4152 weeks$48.01

GRDN as reported

Guardian Pharmacy Services, Inc. reported $1.46B of revenue over the trailing twelve months, +10% on the year before. 7 reported series are charted on this page, each one as filed.

$1.46B

Revenue, trailing twelve months · to Q2 2026 · +10% against the twelve months before

Net income: $66M
Net income · −172% year on year · trailing twelve months to Q2 2026
Operating margin: 5.8%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for GRDN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.46B	+10%	Q2 2026
Net income	$66M	−172%	Q2 2026
Gross margin	22%	n/a	Q2 2026
Operating margin	5.8%	n/a	Q2 2026
Net margin	4.5%	n/a	Q2 2026
ROE	23%	n/a	Q2 2026
ROA	12%	n/a	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.